IO Biotech, a clinical-stage biopharmaceutical company, is revolutionizing cancer therapy with its innovative T-win technology platform, which empowers the immune system to target and disrupt multiple pathways that regulate tumor-induced immunosuppr…

IO Biotech is a clinical-stage biopharmaceutical company advancing novel immune-modulating cancer therapies through its proprietary T-win technology platform.

IO Biotech Inc. is a clinical-stage biopharmaceutical company pioneering innovative cancer therapies through its proprietary T-win technology platform.